Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
Cyclerion Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Cyclerion Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Cyclerion Therapeutics received on average a compensation package of $518K, a 20% decrease compared to previous year.
Andreas Busch, Chief Scientific Officer, received $783K in total, which decreased by 3% compared to 2020. 63% of Busch's compensation, or $492K, was in salary. Busch also received $136K in non-equity incentive plan, $113K in option awards, as well as $41K in other compensation.
Cheryl Gault, Chief Operating Officer, received a compensation package of $664K. 59% of the compensation package, or $395K, was in salary.
Peter M. Hecht, Chief Executive Officer, earned $108K in 2021, a 70% decrease compared to previous year.